Statistics
Total Visits
Views | |
---|---|
Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study(legacy) | 125 |
Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study(legacy) | 85 |
Total Visits per Month
September 2023 | October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | |
---|---|---|---|---|---|---|---|
Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study | 4 | 1 | 4 | 0 | 4 | 3 | 4 |
File Downloads
Views |
---|
Top Country Views
Views | |
---|---|
United States | 85 |
Australia | 37 |
China | 14 |
Netherlands | 8 |
France | 7 |
Vietnam | 6 |
Germany | 2 |
Ireland | 1 |
Sweden | 1 |
Top City Views
Views | |
---|---|
Ashburn | 37 |
Kaleen | 31 |
Fairfield | 12 |
Rotterdam | 8 |
Hanoi | 6 |
Zhengzhou | 5 |
Beijing | 3 |
Cambridge | 3 |
New York | 2 |
San Ramon | 2 |